SCHEMBL5149544

SCHEMBL5149544

O=C(O)Cn1c2ccccc2c2ccc(OCCCCOc3cccc(C(=O)O)c3)cc21

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.54
PSEN1 P49768 4/20 0.51
PSEN2 P49810 4/20 0.51
APH1B Q8WW43 4/20 0.51
NCSTN Q92542 4/20 0.51
APH1A Q96BI3 4/20 0.51
PSENEN Q9NZ42 4/20 0.51
KMT2A Q03164 1/20 0.50
PLA2G4B P0C869 1/20 0.47
NR4A2 P43354 1/20 0.47
GLA P06280 1/20 0.47
NR1H4 Q96RI1 1/20 0.46
CYP4F2 P78329 1/20 0.45
CYP4A11 Q02928 1/20 0.45
PTGDR2 Q9Y5Y4 1/20 0.45
PPARG P37231 1/20 0.45
PPARA Q07869 1/20 0.45
MCL1 Q07820 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5149838 0.92 PSEN1 (0.51) KDM4EPSEN1PSEN2APH1BNCSTN
SCHEMBL5151423 0.91 PSEN1 (0.53) KDM4EPSEN1PSEN2APH1BNCSTN
SCHEMBL5317512 0.90 KDM4E (0.59) KDM4EPSEN1PSEN2APH1BNCSTN
SCHEMBL5149837 0.90 PSEN1 (0.51) KDM4EPSEN1PSEN2APH1BNCSTN
SCHEMBL5318589 0.89 PSEN1 (0.47) KDM4EPSEN1PSEN2APH1BNCSTN
SCHEMBL5317917 0.89 KDM4E (0.60) KDM4EPSEN1PSEN2APH1BNCSTN
SCHEMBL5151892 0.89 FABP4 (0.56) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5152401 0.88 KDM4E (0.54) KDM4EPSEN1PSEN2APH1BNCSTN
SCHEMBL5154718 0.87 KDM4E (0.52) KDM4EPSEN1PSEN2APH1BNCSTN
SCHEMBL5149402 0.87 ATM (0.55) KDM4EPSEN1PSEN2APH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070197524-A1 Fluorenes and carbazoles as ligands of the EP2 receptor BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-08-23 US claimed
US-20070197524-A1 Fluorenes and carbazoles as ligands of the EP2 receptor BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-08-23 US disclosed
US-20070197524-A1 Fluorenes and carbazoles as ligands of the EP2 receptor BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-08-23 US disclosed
US-20070197524-A1 Fluorenes and carbazoles as ligands of the EP2 receptor BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-08-23 US disclosed
WO-2007071456-A1 FLUORENES AND CARBAZOLES AS LIGANDS OF THE EP2 RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197524-A1 Fluorenes and carbazoles as ligands of the EP2 receptor PTGER2, PTGER1, PTGDR2 KDM4E 4330/4885PSEN1 2971/4885PSEN2 1240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.